Paying For Cures With A Value-Based Subscription Model
Quantile’s Access Platform - ‘Netflix’ for Gene Therapies
A value-based subscription model is an alternative payment model for high cost one-time treatments such as gene therapies. This innovative financing solution addresses critical problems facing payers, pharma & patients-
- Pharma: Ensures drug coverage from day one of launch
- Payers: Eliminates budgeting risk and link cost to value
- Patients: Access to transformative medicines
What does Quantile’s Access Platform do?
- Data Collection - Retrieves patient outcome data, and tracks patient care journeys longitudinally and systematically
- Pricing - Disease specific population health models calibrated using real-world payer data allow Quantile’s platform to accurately estimate payer specific subscription price, reflecting each population’s unique risk profile
- Contract Administration - Adjudicate patient outcomes as an impartial third party, and make value-based agreements accessible to payers of all sizes